StonvexLoading…
StonvexCore line items from POST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $2.08B | $4.22B | $2.17B | $8.16B | $5.91B |
Operating Income | Not available | $450.30M | $238.40M | $799.30M | $630.90M |
Net Income | Not available | $178.70M | $96.80M | $335.70M | $284.70M |
EPS (Diluted) | $1.76 | $3.28 | $1.71 | $5.51 | $4.60 |
Total Assets | Not available | $12.98B | $12.98B | $13.53B | $13.37B |
Total Liabilities | Not available | $9.77B | $9.52B | $9.76B | $9.36B |
Cash & Equivalents | Not available | $269.40M | $279.30M | $176.70M | $1.06B |
Free Cash Flow OCF − CapEx | Not available | $270.30M | $119.30M | $488.10M | $336.50M |
Shares Outstanding | Not available | 56.10M | 58.20M | 62.90M | 63.60M |